Patent assignee · US · COMPANY

Precigen, Inc.

🏢 View company profile →
30Patents
29Active
30Granted
50Portfolio score

Filing activity: Jun 7, 2017 → Dec 2, 2022

Most-cited patents

PatentTitleAreaCited byStatus
US10876137B2 Biological production of multi-carbon compounds from methane Emerging Cross-Sectional Technologies 3 Active
US11771718B2 Polypeptide compositions comprising spacers Chemistry; Metallurgy 2 Active
US11118168B2 Expression of novel cell tags Chemistry; Metallurgy 2 Active
US11692194B2 Modulating expression of polypeptides via new gene switch expression systems Chemistry; Metallurgy 1 Active
US11319380B2 MUC16 specific chimeric antigen receptors and uses thereof Chemistry; Metallurgy 1 Active
US11946054B2 Modulating expression of polypeptides via new gene switch expression systems Chemistry; Metallurgy 1 Active
US11821019B2 Biological production of multi-carbon compounds from methane Emerging Cross-Sectional Technologies 1 Active
US11116852B2 Frataxin expression constructs Chemistry; Metallurgy 1 Active
US11535669B2 Fusion constructs and methods of using thereof Chemistry; Metallurgy 1 Active
US12275772B2 ROR-1 specific chimeric antigen receptors and uses thereof Chemistry; Metallurgy 0 Active
US11976134B2 MUC16 specific chimeric antigen receptors and uses thereof Chemistry; Metallurgy 0 Active
US11939584B2 Methods and microorganisms for making 2,3-butanediol and derivatives thereof from C1 carbons Emerging Cross-Sectional Technologies 0 Active
US12060585B2 Expression of novel cell tags Chemistry; Metallurgy 0 Active
US11034940B2 Expression of novel cell tags General 0 Revoked
US11421235B2 Methods and microorganisms for the fermentation of methane to multi-carbon compounds Emerging Cross-Sectional Technologies 0 Active
US12234261B2 Hepatitis B vaccines and uses of the same Chemistry; Metallurgy 0 Active
US11111496B2 Methods and microorganisms for making 2,3-butanediol and derivatives thereof from C1 carbons Emerging Cross-Sectional Technologies 0 Active
US11998618B2 Frataxin expression constructs Chemistry; Metallurgy 0 Active
US12091667B2 Molecular switches Emerging Cross-Sectional Technologies 0 Active
US11981746B2 MUC16 specific chimeric antigen receptors and uses thereof Chemistry; Metallurgy 0 Active
US11198877B2 Molecular switches Emerging Cross-Sectional Technologies 0 Active
US12018310B2 Methods and microorganisms for making 1,4-butanediol and derivatives thereof from C1 carbons Emerging Cross-Sectional Technologies 0 Active
US12194094B2 Fusion constructs and methods of using thereof Chemistry; Metallurgy 0 Active
US11608362B2 Hepatitis B vaccines and uses of the same Chemistry; Metallurgy 0 Active
US11787848B2 CD33 specific chimeric antigen receptors Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.